MedPath

Does Tamsulosin Facilitate Semi-rigid Ureteroscopic

Not Applicable
Conditions
Ureter Stone
Interventions
Procedure: rigid ureteroscopy
Registration Number
NCT04602403
Lead Sponsor
Assiut University
Brief Summary

Ureteric calculi are one of the most common reasons for frequent Urolithiasis. The estimated prevalence is 8-13% of all calculi.

Medical expulsive therapy (MET) is recommended by the European Association of Urology (EAU) (2013) for 5-10 mm ureteric stones to facilitate stone passage. For MET, alpha blockers, mainly tamsulosin, have shown efficacy in several randomized controlled trials. The underlying pathophysiology of this therapy is supported by the presence and distribution of adrenoreceptors in the ureter. Blocking the action of alpha-1 receptors by pharmacological agents (alpha blockers), such as alfuzosin, terazosin, doxazosin, and, most typically, tamsulosin, results in the relaxation of the ureteric smooth muscle.

Ureteroscopy (URS) is the most commonly performed procedure for the treatment of ureteral calculi, with a high (\>90%) stone-free rate after a single treatment. Advancing a rigid ureteroscope into a non-dilated ureter may be difficult and cause complications. Ureteric dilatation may provide access to stones, but not in all cases, and ureteral mucosal injury up to perforation might occur.

Detailed Description

Based on the role of alpha blockers, mainly tamsulosin, in MET of ureteric calculus, the investigator will attempt to extend the use of alpha blockers prior to URS for procedural ease. the investigator will conduct a prospective, randomized double-blind study to evaluate whether alpha blockers facilitate the negotiation of the ureteroscope if administered preoperatively.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Lower ureteral stone.
  • Age: 18 - 75 years.
  • normal renal function.
  • single sided ureteral stone with normal other kideny.
  • sign the informed consent.
  • Be willing/able to adhere to follow up visits.
Exclusion Criteria
  • Upper and middle ureteral stones.
  • renal impairment.
  • Age < 18 years or 75 < years.
  • female who were pregnant
  • bilateral ureteric stone or solitary kidney.
  • urinary tract infection need drainage.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
tamsulosin grouprigid ureteroscopypeople who given tamsulosin to know the effect on ureteroscopy and compare with the control group
placebo grouprigid ureteroscopypeople who given placebo to become agroup of comparison with the other group
Primary Outcome Measures
NameTimeMethod
Number of patients need dilatation below stoneintraoperative

difficult introduce the ureteroscope and reach the stone

Number of patients showing dilated ureteric orificeintraoperative

during ureteroscopy easy introduction in the ureter

Rate of patients develop spontaneous expulsion of stoneup to 3 weeks pre operative

the stone spontaneously expelled without intervension

Number of patients need dormia extraction or forceps without disintegrationintraoperative

that is due to dilated ureter so easy remove the stone

Time of operation from introduction of ureteroscope until stone extractionintraoperative

to know how easy introduction and expulsion of the ureteroscope

Secondary Outcome Measures
NameTimeMethod
Rate of patients developed side effect from tamsulosinup to 3 weeks pre operative

any side effect from alpha blocker

Rate of patients developed complicationintraoperative

any compliction during ureteroscopy such as perforation

Number of patients show residual stone post ureteroscopypostoperative 4 weeks

difficulty in expulsion of all stones

Number of patients show failure of ureteroscopyintraoperative

failed introduction or extraction of stone

Trial Locations

Locations (1)

Mahmoud Ahmed Gaber

🇪🇬

Asyūţ, Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath